While MFR therapy has been extensively studied for musculoskeletal issues, research specifically focusing on penile and testicular applications is limited. Individuals with certain medical conditions, such as acute infections or severe vascular issues, should avoid MFR therapy. It is essential to undergo therapy under professional supervision to mitigate these risks. Many osteopathic physicians are trained in myofascial release therapy. If you’re interested in myofascial release therapy, talk with your healthcare provider. They may suggest avoiding myofascial release therapy or trying a different kind of therapy. But myofascial release therapy has many potential benefits. After your provider performs myofascial release therapy, you may feel sore in the areas they stretched. This is because myofascial pain originates in various trigger points in your body. Administration of testosterone to females or orchiectomized males produced unilateral, shorter lasting hyperalgesia. In addition, pain can also be generated from damaged myofascial tissue itself, sometimes at a 'trigger point' where a contraction of muscle fibers has occurred. Many patients seek myofascial treatment after losing flexibility or function following an injury or if experiencing ongoing back, shoulder, hip, or virtually pain in any area containing soft tissue. On the other hand, estrogen fluctuations provide an explanation for the lower pain threshold seen in females. However, more recent studies show that testosterone also plays a role in the sexual dimorphism of pain. Sex differences in the prevalence of pain conditions are not present in children until puberty suggesting a role for sex hormones 6;30. Sex differences are present in both the symptomology and prevalence of chronic pain conditions. Lastly, certain pain conditions afflict females more than males making this population especially vulnerable for the psychological side effects of pain . In the Aloisi et al. study, 11 of 14 transgender females reported breast pain, always arising after the start of hormone therapy, in more than 50% unilateral and continuous. Cross-sex therapy with testosterone and estrogens was administered to intact rats of both genders, after which a decrease in pain duration and intensity was noted in female rats, but no such significant difference was seen in intact male rats. These findings suggest that steady levels of estrogens promote less pain perception in females, while sudden drops and fluctuations are major contributors to the increased pain in females with fibromyalgia . The result of therapeutic models using testosterone gel for the treatment of fibromyalgia was consistent with the hypothesized role for the hormone, with clinical improvement evidenced in the target population of 11 biological male and female patients . Schertzinger et al. performed serum level measurements of various hormones in female patients with fibromyalgia correlating with changes in pain presentation during the normal menstrual cycle and found a significant inverse relationship between progesterone and testosterone and pain, and no association with estrogen or cortisol levels. By identifying and applying pressure to these points, MFR therapy can effectively reduce referred pain in the penis and testicles. Trigger points, or localized areas of intense muscle tightness, can refer pain to other parts of the body. This technique involves applying gentle, sustained pressure to the myofascial tissues to stretch and loosen tight fascia. MFR therapy enhances the flexibility of the pelvic tissues, reducing stiffness and increasing the range of motion. Conditions such as chronic prostatitis, erectile dysfunction, and testicular discomfort are often linked to stress and tightness in these muscles. This biochemical change is considered to play a major role in pain hypersensitivity in males because testosterone replacement therapy in these rats reduced musculoskeletal pain. In the female transgender group, 14 patients (29.8%) reported pain on 78% of the occasions with the onset after hormone therapy. Fluctuations of estrogen and their contributions to elevated CGRP and tryptophan confirm the involvement of sex hormones in headaches seen in biological females . Also for this project, I updated all references made to my work as a massage therapist, a great many of which still read like I have appointments schedule next week, when in fact I haven’t seen massage therapy client in over a decade now. Thank you for delivering information about trigger points and resulting pain in a manner that is understandable to the general public. (See also Seminarios Travell & Simons, offering trigger point courses in Spain led by Orlando Mayoral — there is a regular exchange of experience between DGSA and Orlando Mayoral.)|Sex hormones play a role in the differences in pain experienced by males and females, and patients receiving hormone therapy. Compared to biological females, transgender men tend to experience higher levels of pain during the procedure despite being on testosterone replacement therapy . Further, the significantly increased levels of testosterone in biological males may explain the lower prevalence of chronic pain conditions in males compared to females . In this manuscript, the available literature describing the differences in pain perception and pain-related conditions in biological males and females, the transgender population undergoing sex hormone therapy will be reviewed. The current study showed increases in SERT in the NRM following induction of the activity-induced pain model only in females. This experiment tested if orchiectomy surgery could reverse the sex-dependent effects observed in pain behavior between males and females when the muscle fatigue is administered 24 hours before the final muscle insult. This experiment tested if orchiectomy surgery could reverse the sex-dependent effects observed in pain behavior between males and females when the muscle fatigue and final muscle insult are delivered in opposite muscles.} In addition to minor aches and pains, muscle pain often causes unusual symptoms in strange locations. Long ago, in 1997, I had a brutal "toothache" … that was banished by a bit of massage therapy on my jaw the day before an urgent appointment with my dentist. The "tender points" of fibromyalgia are not the same idea as myofascial trigger points. Fibromyalgia is a syndrome, not a disease, which means that it is unexplained by definition.39 It is just the label we give to a pattern of undiagnosed chronic widespread body pain. — but anyone who claims to treat muscle pain should still have the big red books in their office. I avoided publishing this section of the tutorial for many years, because I am generally not impressed by the resources available (to both patients and professionals), especially online resources. It’s illustrated nicely, and offers detailed muscle-by-muscle reference material — things this tutorial deliberately lacks. You don’t really need the link to every common pain problem spelled out.